Bruce L. A. Carter, Director at Mirati Therapeutics, Inc. (MRTX), sold 2,990 shares at $126.71 ($378K) on 2020-08-11, disclosed to the SEC on 2020-08-13.
Open-market sale of $378k MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.78 | 1,300 | $164K | 43.2% |
| 2 | $126.71 | 740 | $94K | 24.8% |
| 3 | $126.71 | 740 | $94K | 24.8% |
| 4 | $127.58 | 110 | $14K | 3.7% |
| 5 | $131.16 | 100 | $13K | 3.5% |
| Total | $126.49 avg | 2,990 |
| $378K |
| 100% |
| Filing → |
| MRTX | SELL | 2021-04-06 | $746K | — | Filing → |
| MRTX | SELL | 2021-02-03 | $430K | — | Filing → |
| MRTX | SELL | 2020-12-16 | $1.1M | — | Filing → |